Lectures and seminars OnkPat Friday Seminar: From cancer vaccines to adoptive T cell therapy: Advancing Immunotherapy strategies in solid cancer
Welcome to OnkPat Friday Seminar with Else Marit Inderberg, PhD and Principal Investigator at Oslo University Hospital.
Learn more about Else Marit Inderberg
Selected Publications
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM
Mol Ther 2026 Sep;():
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM
Mol Ther 2024 Jun;32(6):2021-2029
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.
Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S
Cell Rep Med 2025 Sep;6(9):102350